Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m(6)A Regulators

BACKGROUND: Esophagus cancer (ESCA) is the sixth most frequent cancer in males, with 5-year overall survival of 15%–25%. RNA modifications function critically in cancer progression, and m(6)A regulators are associated with ESCA prognosis. This study further revealed correlations between m(6)A and ES...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianjun, Zhu, Hongbo, Yang, Qiao, Xiao, Hua, Wu, Haibiao, Fang, Zhe, Li, Wenjun, Cai, Manbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776445/
https://www.ncbi.nlm.nih.gov/pubmed/35069736
http://dx.doi.org/10.1155/2022/5490461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776445/
https://www.ncbi.nlm.nih.gov/pubmed/35069736
http://dx.doi.org/10.1155/2022/5490461

Ejemplares similares